Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashok Kumar Jayavelu

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Experimental Hematology|September 27, 2016
NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AMLAshok Kumar Jayavelu, Jennifer N Moloney, Frank-D Böhmer, et al.
The EMBO Journal|November 15, 2024
Redistribution of PU.1 partner transcription factor RUNX1 binding secures cell survival during leukemogenesisAlexander Bender, Füsun Boydere, Ashok Kumar Jayavelu, et al.
Oncotarget|December 30, 2017
Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AMLJennifer N Moloney, Ashok Kumar Jayavelu, Joanna Stanicka, et al.
Oncotarget|May 3, 2017
Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylationDimitrios Tsitsipatis, Ashok Kumar Jayavelu, Jörg P Müller, et al.
Nature Communications|January 4, 2023
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosisHirofumi Nagao, Ashok Kumar Jayavelu, Weikang Cai, et al.
The Journal of Clinical Investigation|September 10, 2021
Signaling defects associated with insulin resistance in nondiabetic and diabetic individuals and modification by sexNida Haider, Jasmin Lebastchi, Ashok Kumar Jayavelu, et al.
The Journal of Clinical Investigation|April 15, 2025
Cell-intrinsic insulin signaling defects in human iPS cell-derived hepatocytes in type 2 diabetesArijeet K Gattu, Maria Tanzer, Tomer M Yaron-Barir, et al.
Journal of Hematology & Oncology|March 13, 2022
Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patientsChristina Zeller, Daniel Richter, Vindi Jurinovic, et al.
Cell Metabolism|September 5, 2020
A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 DiabetesThiago M Batista, Ashok Kumar Jayavelu, Nicolai J Wewer Albrechtsen, et al.
Frontiers in Oncology|August 25, 2022
Presence of the <i>GFI1-36N</i> single nucleotide polymorphism enhances the response of <i>MLL-AF9</i> leukemic cells to CDK4/6 inhibitionJan Vorwerk, Kaiyan Sun, Daria Frank, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Experimental Hematology|September 27, 2016
NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AMLAshok Kumar Jayavelu, Jennifer N Moloney, Frank-D Böhmer, et al.
The EMBO Journal|November 15, 2024
Redistribution of PU.1 partner transcription factor RUNX1 binding secures cell survival during leukemogenesisAlexander Bender, Füsun Boydere, Ashok Kumar Jayavelu, et al.
Oncotarget|December 30, 2017
Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AMLJennifer N Moloney, Ashok Kumar Jayavelu, Joanna Stanicka, et al.
Oncotarget|May 3, 2017
Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylationDimitrios Tsitsipatis, Ashok Kumar Jayavelu, Jörg P Müller, et al.
Nature Communications|January 4, 2023
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosisHirofumi Nagao, Ashok Kumar Jayavelu, Weikang Cai, et al.
The Journal of Clinical Investigation|September 10, 2021
Signaling defects associated with insulin resistance in nondiabetic and diabetic individuals and modification by sexNida Haider, Jasmin Lebastchi, Ashok Kumar Jayavelu, et al.
The Journal of Clinical Investigation|April 15, 2025
Cell-intrinsic insulin signaling defects in human iPS cell-derived hepatocytes in type 2 diabetesArijeet K Gattu, Maria Tanzer, Tomer M Yaron-Barir, et al.
Journal of Hematology & Oncology|March 13, 2022
Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patientsChristina Zeller, Daniel Richter, Vindi Jurinovic, et al.
Cell Metabolism|September 5, 2020
A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 DiabetesThiago M Batista, Ashok Kumar Jayavelu, Nicolai J Wewer Albrechtsen, et al.
Frontiers in Oncology|August 25, 2022
Presence of the <i>GFI1-36N</i> single nucleotide polymorphism enhances the response of <i>MLL-AF9</i> leukemic cells to CDK4/6 inhibitionJan Vorwerk, Kaiyan Sun, Daria Frank, et al.
Pageof 3